Pulmonary arterial hypertension after systemic‑to‑pulmonary shunt correction (RCD code: II-1A.4d)
Journal Title: Journal of Rare Cardiovascular Diseases - Year 2013, Vol 1, Issue 3
Abstract
Pulmonary arterial hypertension develops in a significant number of patients with congenital heart diseases. Congenital heart diseases predispose to pulmonary vascular remodeling as a result of increased pulmonary blood flow and increased pulmonary pressure. Pulmonary arterial hypertension associated with congenital heart diseases is a major determinant of functional capacity and survival in this group of patients. JRCD 2013; 1 (3): 32–35
Authors and Affiliations
Magdalena Kaznica-Wiatr, Grzegorz Kopeć, Piotr Podolec
Keywords
Related Articles
- EP ID EP245390
- DOI 10.20418/jrcd.vol1no3.91
- Views 102
- Downloads 0
Cardiac manifestations in a two‑generation family with Fabry disease (RCD code: III‑2B.2a)
Fabry disease (FD), which is also called angiokeratoma corporis difusum, ceramide trihexosidosis, and Anderson-Fabry disease, is an X-linked inborn error of metabolism of glycosphingolipid pathway. It is caused by the de...
Journal of Rare Cardiovascular Diseases: Another exciting quarter in the ‘usual’ life of the Journal
Dear Friends and Colleagues,Our Dear Readers and Supporters of the Journal,It is an extreme pleasure to deliver at your hand the 7th issue of the Journal of Rare Cardiovascular Diseases. Our two‑year anniversary has not...
Patient with multiple myeloma and suspected cardiac amyloidosis (RCD code: III‑3A.2a)
49 year‑old patient with multiple myeloma diagnosed a year earlier, after a few cycles of chemotherapy was admitted to hospital with heart failure symptoms accompanied by a rapid atrial flutter. Echocardiography revealed...
Safety of pulmonary vein isolation in atrial fibrillation patients treated with dabigatran when idarucizumab is available
Patients with atrial fibrillation (AF) are at increased risk of stroke and systemic thromboembolism and prevention of such episodes is ensured by choosing appropriate anticoagulation. In paroxysmal drug‐refractory AF, ca...
1st International Conference on Rare Cardiovascular Diseases (Krakow, October 18–19, 2012)
Doctors, like other academic professionals, know very well that there is no better place than a live conference to share knowledge and experience or to interact with people of similar interests.Encouraged by the success...